Cargos activos de Renee T. Leck
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Contacto de Relaciones con Inversores | - | - |
Historial de carrera de Renee T. Leck
Antiguos cargos conocidos de Renee T. Leck.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Public Communications Contact | 01/05/2015 | 01/12/2018 |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Reino Unido | 2 |
Operativa
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Renee T. Leck
- Experiencia
